Global Carbapenem Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Carbapenem Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Carbapenem antibacterial drugs have a broad antibacterial spectrum and strong antibacterial activity. They have antibacterial effects on both aerobic and anaerobic bacteria, especially on multi-drug resistant Gram-negative bacilli, such as extended-spectrum ?-lactamase-producing ( ESBL) Enterobacteriaceae bacteria have strong antibacterial activity. This type of drug has a wide range of clinical indications and plays an important role in the antibacterial treatment of multi-drug-resistant bacterial infections, mixed infections of aerobic and anaerobic bacteria, severe infections and infections in patients with immunodeficiency.
The Global Info Research report includes an overview of the development of the Carbapenem Drugs industry chain, the market status of Hospital (Doripenem, Ertapenem), Clinic (Doripenem, Ertapenem), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Carbapenem Drugs.
Regionally, the report analyzes the Carbapenem Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Carbapenem Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Carbapenem Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Carbapenem Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Doripenem, Ertapenem).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Carbapenem Drugs market.
Regional Analysis: The report involves examining the Carbapenem Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Carbapenem Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Carbapenem Drugs:
Company Analysis: Report covers individual Carbapenem Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Carbapenem Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Carbapenem Drugs. It assesses the current state, advancements, and potential future developments in Carbapenem Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Carbapenem Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Carbapenem Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Carbapenem Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Carbapenem Drugs, with price, sales, revenue and global market share of Carbapenem Drugs from 2019 to 2024.
Chapter 3, the Carbapenem Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Carbapenem Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Carbapenem Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Carbapenem Drugs.
Chapter 14 and 15, to describe Carbapenem Drugs sales channel, distributors, customers, research findings and conclusion.
Carbapenem antibacterial drugs have a broad antibacterial spectrum and strong antibacterial activity. They have antibacterial effects on both aerobic and anaerobic bacteria, especially on multi-drug resistant Gram-negative bacilli, such as extended-spectrum ?-lactamase-producing ( ESBL) Enterobacteriaceae bacteria have strong antibacterial activity. This type of drug has a wide range of clinical indications and plays an important role in the antibacterial treatment of multi-drug-resistant bacterial infections, mixed infections of aerobic and anaerobic bacteria, severe infections and infections in patients with immunodeficiency.
The Global Info Research report includes an overview of the development of the Carbapenem Drugs industry chain, the market status of Hospital (Doripenem, Ertapenem), Clinic (Doripenem, Ertapenem), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Carbapenem Drugs.
Regionally, the report analyzes the Carbapenem Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Carbapenem Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Carbapenem Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Carbapenem Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Doripenem, Ertapenem).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Carbapenem Drugs market.
Regional Analysis: The report involves examining the Carbapenem Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Carbapenem Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Carbapenem Drugs:
Company Analysis: Report covers individual Carbapenem Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Carbapenem Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Carbapenem Drugs. It assesses the current state, advancements, and potential future developments in Carbapenem Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Carbapenem Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Carbapenem Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Doripenem
- Ertapenem
- Imipenem
- Meropenem
- Panipenem
- Biapenem
- Hospital
- Clinic
- Others
- Shandong New Era Pharmaceutical
- Shenzhen Haibin Pharmaceutical
- Sinopharm Guorui Pharmaceutical
- Taiwan Biotech Co., Ltd.
- Merck
- Sun Pharmaceutical Industries Ltd.
- JW Pharmaceutical
- Zhengde Pharmaceutical
- Hospira Inc.
- WG Critical Care
- Hanhui Pharmaceutical
- Zhuhai United Laboratories
- ACS Dobfar S.p.A
- Iterum Therapeutics plc (ITRM)
- Daewoong Pharmaceutical
- Aurobindo Pharma Ltd
- Sumitomo Pharma
- Pfizer Inc.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Carbapenem Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Carbapenem Drugs, with price, sales, revenue and global market share of Carbapenem Drugs from 2019 to 2024.
Chapter 3, the Carbapenem Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Carbapenem Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Carbapenem Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Carbapenem Drugs.
Chapter 14 and 15, to describe Carbapenem Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Carbapenem Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Carbapenem Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Doripenem
1.3.3 Ertapenem
1.3.4 Imipenem
1.3.5 Meropenem
1.3.6 Panipenem
1.3.7 Biapenem
1.4 Market Analysis by Application
1.4.1 Overview: Global Carbapenem Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Carbapenem Drugs Market Size & Forecast
1.5.1 Global Carbapenem Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Carbapenem Drugs Sales Quantity (2019-2030)
1.5.3 Global Carbapenem Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Shandong New Era Pharmaceutical
2.1.1 Shandong New Era Pharmaceutical Details
2.1.2 Shandong New Era Pharmaceutical Major Business
2.1.3 Shandong New Era Pharmaceutical Carbapenem Drugs Product and Services
2.1.4 Shandong New Era Pharmaceutical Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Shandong New Era Pharmaceutical Recent Developments/Updates
2.2 Shenzhen Haibin Pharmaceutical
2.2.1 Shenzhen Haibin Pharmaceutical Details
2.2.2 Shenzhen Haibin Pharmaceutical Major Business
2.2.3 Shenzhen Haibin Pharmaceutical Carbapenem Drugs Product and Services
2.2.4 Shenzhen Haibin Pharmaceutical Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
2.3 Sinopharm Guorui Pharmaceutical
2.3.1 Sinopharm Guorui Pharmaceutical Details
2.3.2 Sinopharm Guorui Pharmaceutical Major Business
2.3.3 Sinopharm Guorui Pharmaceutical Carbapenem Drugs Product and Services
2.3.4 Sinopharm Guorui Pharmaceutical Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Sinopharm Guorui Pharmaceutical Recent Developments/Updates
2.4 Taiwan Biotech Co., Ltd.
2.4.1 Taiwan Biotech Co., Ltd. Details
2.4.2 Taiwan Biotech Co., Ltd. Major Business
2.4.3 Taiwan Biotech Co., Ltd. Carbapenem Drugs Product and Services
2.4.4 Taiwan Biotech Co., Ltd. Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Taiwan Biotech Co., Ltd. Recent Developments/Updates
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Carbapenem Drugs Product and Services
2.5.4 Merck Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Merck Recent Developments/Updates
2.6 Sun Pharmaceutical Industries Ltd.
2.6.1 Sun Pharmaceutical Industries Ltd. Details
2.6.2 Sun Pharmaceutical Industries Ltd. Major Business
2.6.3 Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Product and Services
2.6.4 Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
2.7 JW Pharmaceutical
2.7.1 JW Pharmaceutical Details
2.7.2 JW Pharmaceutical Major Business
2.7.3 JW Pharmaceutical Carbapenem Drugs Product and Services
2.7.4 JW Pharmaceutical Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 JW Pharmaceutical Recent Developments/Updates
2.8 Zhengde Pharmaceutical
2.8.1 Zhengde Pharmaceutical Details
2.8.2 Zhengde Pharmaceutical Major Business
2.8.3 Zhengde Pharmaceutical Carbapenem Drugs Product and Services
2.8.4 Zhengde Pharmaceutical Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Zhengde Pharmaceutical Recent Developments/Updates
2.9 Hospira Inc.
2.9.1 Hospira Inc. Details
2.9.2 Hospira Inc. Major Business
2.9.3 Hospira Inc. Carbapenem Drugs Product and Services
2.9.4 Hospira Inc. Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Hospira Inc. Recent Developments/Updates
2.10 WG Critical Care
2.10.1 WG Critical Care Details
2.10.2 WG Critical Care Major Business
2.10.3 WG Critical Care Carbapenem Drugs Product and Services
2.10.4 WG Critical Care Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 WG Critical Care Recent Developments/Updates
2.11 Hanhui Pharmaceutical
2.11.1 Hanhui Pharmaceutical Details
2.11.2 Hanhui Pharmaceutical Major Business
2.11.3 Hanhui Pharmaceutical Carbapenem Drugs Product and Services
2.11.4 Hanhui Pharmaceutical Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Hanhui Pharmaceutical Recent Developments/Updates
2.12 Zhuhai United Laboratories
2.12.1 Zhuhai United Laboratories Details
2.12.2 Zhuhai United Laboratories Major Business
2.12.3 Zhuhai United Laboratories Carbapenem Drugs Product and Services
2.12.4 Zhuhai United Laboratories Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Zhuhai United Laboratories Recent Developments/Updates
2.13 ACS Dobfar S.p.A
2.13.1 ACS Dobfar S.p.A Details
2.13.2 ACS Dobfar S.p.A Major Business
2.13.3 ACS Dobfar S.p.A Carbapenem Drugs Product and Services
2.13.4 ACS Dobfar S.p.A Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 ACS Dobfar S.p.A Recent Developments/Updates
2.14 Iterum Therapeutics plc (ITRM)
2.14.1 Iterum Therapeutics plc (ITRM) Details
2.14.2 Iterum Therapeutics plc (ITRM) Major Business
2.14.3 Iterum Therapeutics plc (ITRM) Carbapenem Drugs Product and Services
2.14.4 Iterum Therapeutics plc (ITRM) Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Iterum Therapeutics plc (ITRM) Recent Developments/Updates
2.15 Daewoong Pharmaceutical
2.15.1 Daewoong Pharmaceutical Details
2.15.2 Daewoong Pharmaceutical Major Business
2.15.3 Daewoong Pharmaceutical Carbapenem Drugs Product and Services
2.15.4 Daewoong Pharmaceutical Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Daewoong Pharmaceutical Recent Developments/Updates
2.16 Aurobindo Pharma Ltd
2.16.1 Aurobindo Pharma Ltd Details
2.16.2 Aurobindo Pharma Ltd Major Business
2.16.3 Aurobindo Pharma Ltd Carbapenem Drugs Product and Services
2.16.4 Aurobindo Pharma Ltd Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Aurobindo Pharma Ltd Recent Developments/Updates
2.17 Sumitomo Pharma
2.17.1 Sumitomo Pharma Details
2.17.2 Sumitomo Pharma Major Business
2.17.3 Sumitomo Pharma Carbapenem Drugs Product and Services
2.17.4 Sumitomo Pharma Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Sumitomo Pharma Recent Developments/Updates
2.18 Pfizer Inc.
2.18.1 Pfizer Inc. Details
2.18.2 Pfizer Inc. Major Business
2.18.3 Pfizer Inc. Carbapenem Drugs Product and Services
2.18.4 Pfizer Inc. Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Pfizer Inc. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CARBAPENEM DRUGS BY MANUFACTURER
3.1 Global Carbapenem Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Carbapenem Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Carbapenem Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Carbapenem Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Carbapenem Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Carbapenem Drugs Manufacturer Market Share in 2023
3.5 Carbapenem Drugs Market: Overall Company Footprint Analysis
3.5.1 Carbapenem Drugs Market: Region Footprint
3.5.2 Carbapenem Drugs Market: Company Product Type Footprint
3.5.3 Carbapenem Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Carbapenem Drugs Market Size by Region
4.1.1 Global Carbapenem Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Carbapenem Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Carbapenem Drugs Average Price by Region (2019-2030)
4.2 North America Carbapenem Drugs Consumption Value (2019-2030)
4.3 Europe Carbapenem Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Carbapenem Drugs Consumption Value (2019-2030)
4.5 South America Carbapenem Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Carbapenem Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Carbapenem Drugs Sales Quantity by Type (2019-2030)
5.2 Global Carbapenem Drugs Consumption Value by Type (2019-2030)
5.3 Global Carbapenem Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Carbapenem Drugs Sales Quantity by Application (2019-2030)
6.2 Global Carbapenem Drugs Consumption Value by Application (2019-2030)
6.3 Global Carbapenem Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Carbapenem Drugs Sales Quantity by Type (2019-2030)
7.2 North America Carbapenem Drugs Sales Quantity by Application (2019-2030)
7.3 North America Carbapenem Drugs Market Size by Country
7.3.1 North America Carbapenem Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Carbapenem Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Carbapenem Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Carbapenem Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Carbapenem Drugs Market Size by Country
8.3.1 Europe Carbapenem Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Carbapenem Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Carbapenem Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Carbapenem Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Carbapenem Drugs Market Size by Region
9.3.1 Asia-Pacific Carbapenem Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Carbapenem Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Carbapenem Drugs Sales Quantity by Type (2019-2030)
10.2 South America Carbapenem Drugs Sales Quantity by Application (2019-2030)
10.3 South America Carbapenem Drugs Market Size by Country
10.3.1 South America Carbapenem Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Carbapenem Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Carbapenem Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Carbapenem Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Carbapenem Drugs Market Size by Country
11.3.1 Middle East & Africa Carbapenem Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Carbapenem Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Carbapenem Drugs Market Drivers
12.2 Carbapenem Drugs Market Restraints
12.3 Carbapenem Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Carbapenem Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Carbapenem Drugs
13.3 Carbapenem Drugs Production Process
13.4 Carbapenem Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Carbapenem Drugs Typical Distributors
14.3 Carbapenem Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Carbapenem Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Carbapenem Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Doripenem
1.3.3 Ertapenem
1.3.4 Imipenem
1.3.5 Meropenem
1.3.6 Panipenem
1.3.7 Biapenem
1.4 Market Analysis by Application
1.4.1 Overview: Global Carbapenem Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Carbapenem Drugs Market Size & Forecast
1.5.1 Global Carbapenem Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Carbapenem Drugs Sales Quantity (2019-2030)
1.5.3 Global Carbapenem Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Shandong New Era Pharmaceutical
2.1.1 Shandong New Era Pharmaceutical Details
2.1.2 Shandong New Era Pharmaceutical Major Business
2.1.3 Shandong New Era Pharmaceutical Carbapenem Drugs Product and Services
2.1.4 Shandong New Era Pharmaceutical Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Shandong New Era Pharmaceutical Recent Developments/Updates
2.2 Shenzhen Haibin Pharmaceutical
2.2.1 Shenzhen Haibin Pharmaceutical Details
2.2.2 Shenzhen Haibin Pharmaceutical Major Business
2.2.3 Shenzhen Haibin Pharmaceutical Carbapenem Drugs Product and Services
2.2.4 Shenzhen Haibin Pharmaceutical Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
2.3 Sinopharm Guorui Pharmaceutical
2.3.1 Sinopharm Guorui Pharmaceutical Details
2.3.2 Sinopharm Guorui Pharmaceutical Major Business
2.3.3 Sinopharm Guorui Pharmaceutical Carbapenem Drugs Product and Services
2.3.4 Sinopharm Guorui Pharmaceutical Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Sinopharm Guorui Pharmaceutical Recent Developments/Updates
2.4 Taiwan Biotech Co., Ltd.
2.4.1 Taiwan Biotech Co., Ltd. Details
2.4.2 Taiwan Biotech Co., Ltd. Major Business
2.4.3 Taiwan Biotech Co., Ltd. Carbapenem Drugs Product and Services
2.4.4 Taiwan Biotech Co., Ltd. Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Taiwan Biotech Co., Ltd. Recent Developments/Updates
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Carbapenem Drugs Product and Services
2.5.4 Merck Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Merck Recent Developments/Updates
2.6 Sun Pharmaceutical Industries Ltd.
2.6.1 Sun Pharmaceutical Industries Ltd. Details
2.6.2 Sun Pharmaceutical Industries Ltd. Major Business
2.6.3 Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Product and Services
2.6.4 Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
2.7 JW Pharmaceutical
2.7.1 JW Pharmaceutical Details
2.7.2 JW Pharmaceutical Major Business
2.7.3 JW Pharmaceutical Carbapenem Drugs Product and Services
2.7.4 JW Pharmaceutical Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 JW Pharmaceutical Recent Developments/Updates
2.8 Zhengde Pharmaceutical
2.8.1 Zhengde Pharmaceutical Details
2.8.2 Zhengde Pharmaceutical Major Business
2.8.3 Zhengde Pharmaceutical Carbapenem Drugs Product and Services
2.8.4 Zhengde Pharmaceutical Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Zhengde Pharmaceutical Recent Developments/Updates
2.9 Hospira Inc.
2.9.1 Hospira Inc. Details
2.9.2 Hospira Inc. Major Business
2.9.3 Hospira Inc. Carbapenem Drugs Product and Services
2.9.4 Hospira Inc. Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Hospira Inc. Recent Developments/Updates
2.10 WG Critical Care
2.10.1 WG Critical Care Details
2.10.2 WG Critical Care Major Business
2.10.3 WG Critical Care Carbapenem Drugs Product and Services
2.10.4 WG Critical Care Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 WG Critical Care Recent Developments/Updates
2.11 Hanhui Pharmaceutical
2.11.1 Hanhui Pharmaceutical Details
2.11.2 Hanhui Pharmaceutical Major Business
2.11.3 Hanhui Pharmaceutical Carbapenem Drugs Product and Services
2.11.4 Hanhui Pharmaceutical Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Hanhui Pharmaceutical Recent Developments/Updates
2.12 Zhuhai United Laboratories
2.12.1 Zhuhai United Laboratories Details
2.12.2 Zhuhai United Laboratories Major Business
2.12.3 Zhuhai United Laboratories Carbapenem Drugs Product and Services
2.12.4 Zhuhai United Laboratories Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Zhuhai United Laboratories Recent Developments/Updates
2.13 ACS Dobfar S.p.A
2.13.1 ACS Dobfar S.p.A Details
2.13.2 ACS Dobfar S.p.A Major Business
2.13.3 ACS Dobfar S.p.A Carbapenem Drugs Product and Services
2.13.4 ACS Dobfar S.p.A Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 ACS Dobfar S.p.A Recent Developments/Updates
2.14 Iterum Therapeutics plc (ITRM)
2.14.1 Iterum Therapeutics plc (ITRM) Details
2.14.2 Iterum Therapeutics plc (ITRM) Major Business
2.14.3 Iterum Therapeutics plc (ITRM) Carbapenem Drugs Product and Services
2.14.4 Iterum Therapeutics plc (ITRM) Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Iterum Therapeutics plc (ITRM) Recent Developments/Updates
2.15 Daewoong Pharmaceutical
2.15.1 Daewoong Pharmaceutical Details
2.15.2 Daewoong Pharmaceutical Major Business
2.15.3 Daewoong Pharmaceutical Carbapenem Drugs Product and Services
2.15.4 Daewoong Pharmaceutical Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Daewoong Pharmaceutical Recent Developments/Updates
2.16 Aurobindo Pharma Ltd
2.16.1 Aurobindo Pharma Ltd Details
2.16.2 Aurobindo Pharma Ltd Major Business
2.16.3 Aurobindo Pharma Ltd Carbapenem Drugs Product and Services
2.16.4 Aurobindo Pharma Ltd Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Aurobindo Pharma Ltd Recent Developments/Updates
2.17 Sumitomo Pharma
2.17.1 Sumitomo Pharma Details
2.17.2 Sumitomo Pharma Major Business
2.17.3 Sumitomo Pharma Carbapenem Drugs Product and Services
2.17.4 Sumitomo Pharma Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Sumitomo Pharma Recent Developments/Updates
2.18 Pfizer Inc.
2.18.1 Pfizer Inc. Details
2.18.2 Pfizer Inc. Major Business
2.18.3 Pfizer Inc. Carbapenem Drugs Product and Services
2.18.4 Pfizer Inc. Carbapenem Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Pfizer Inc. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CARBAPENEM DRUGS BY MANUFACTURER
3.1 Global Carbapenem Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Carbapenem Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Carbapenem Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Carbapenem Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Carbapenem Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Carbapenem Drugs Manufacturer Market Share in 2023
3.5 Carbapenem Drugs Market: Overall Company Footprint Analysis
3.5.1 Carbapenem Drugs Market: Region Footprint
3.5.2 Carbapenem Drugs Market: Company Product Type Footprint
3.5.3 Carbapenem Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Carbapenem Drugs Market Size by Region
4.1.1 Global Carbapenem Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Carbapenem Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Carbapenem Drugs Average Price by Region (2019-2030)
4.2 North America Carbapenem Drugs Consumption Value (2019-2030)
4.3 Europe Carbapenem Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Carbapenem Drugs Consumption Value (2019-2030)
4.5 South America Carbapenem Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Carbapenem Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Carbapenem Drugs Sales Quantity by Type (2019-2030)
5.2 Global Carbapenem Drugs Consumption Value by Type (2019-2030)
5.3 Global Carbapenem Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Carbapenem Drugs Sales Quantity by Application (2019-2030)
6.2 Global Carbapenem Drugs Consumption Value by Application (2019-2030)
6.3 Global Carbapenem Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Carbapenem Drugs Sales Quantity by Type (2019-2030)
7.2 North America Carbapenem Drugs Sales Quantity by Application (2019-2030)
7.3 North America Carbapenem Drugs Market Size by Country
7.3.1 North America Carbapenem Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Carbapenem Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Carbapenem Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Carbapenem Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Carbapenem Drugs Market Size by Country
8.3.1 Europe Carbapenem Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Carbapenem Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Carbapenem Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Carbapenem Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Carbapenem Drugs Market Size by Region
9.3.1 Asia-Pacific Carbapenem Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Carbapenem Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Carbapenem Drugs Sales Quantity by Type (2019-2030)
10.2 South America Carbapenem Drugs Sales Quantity by Application (2019-2030)
10.3 South America Carbapenem Drugs Market Size by Country
10.3.1 South America Carbapenem Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Carbapenem Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Carbapenem Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Carbapenem Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Carbapenem Drugs Market Size by Country
11.3.1 Middle East & Africa Carbapenem Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Carbapenem Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Carbapenem Drugs Market Drivers
12.2 Carbapenem Drugs Market Restraints
12.3 Carbapenem Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Carbapenem Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Carbapenem Drugs
13.3 Carbapenem Drugs Production Process
13.4 Carbapenem Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Carbapenem Drugs Typical Distributors
14.3 Carbapenem Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Carbapenem Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Carbapenem Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Shandong New Era Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Shandong New Era Pharmaceutical Major Business
Table 5. Shandong New Era Pharmaceutical Carbapenem Drugs Product and Services
Table 6. Shandong New Era Pharmaceutical Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Shandong New Era Pharmaceutical Recent Developments/Updates
Table 8. Shenzhen Haibin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 9. Shenzhen Haibin Pharmaceutical Major Business
Table 10. Shenzhen Haibin Pharmaceutical Carbapenem Drugs Product and Services
Table 11. Shenzhen Haibin Pharmaceutical Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 13. Sinopharm Guorui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. Sinopharm Guorui Pharmaceutical Major Business
Table 15. Sinopharm Guorui Pharmaceutical Carbapenem Drugs Product and Services
Table 16. Sinopharm Guorui Pharmaceutical Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Sinopharm Guorui Pharmaceutical Recent Developments/Updates
Table 18. Taiwan Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 19. Taiwan Biotech Co., Ltd. Major Business
Table 20. Taiwan Biotech Co., Ltd. Carbapenem Drugs Product and Services
Table 21. Taiwan Biotech Co., Ltd. Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Taiwan Biotech Co., Ltd. Recent Developments/Updates
Table 23. Merck Basic Information, Manufacturing Base and Competitors
Table 24. Merck Major Business
Table 25. Merck Carbapenem Drugs Product and Services
Table 26. Merck Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Merck Recent Developments/Updates
Table 28. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Sun Pharmaceutical Industries Ltd. Major Business
Table 30. Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Product and Services
Table 31. Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 33. JW Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. JW Pharmaceutical Major Business
Table 35. JW Pharmaceutical Carbapenem Drugs Product and Services
Table 36. JW Pharmaceutical Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. JW Pharmaceutical Recent Developments/Updates
Table 38. Zhengde Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Zhengde Pharmaceutical Major Business
Table 40. Zhengde Pharmaceutical Carbapenem Drugs Product and Services
Table 41. Zhengde Pharmaceutical Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Zhengde Pharmaceutical Recent Developments/Updates
Table 43. Hospira Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Hospira Inc. Major Business
Table 45. Hospira Inc. Carbapenem Drugs Product and Services
Table 46. Hospira Inc. Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Hospira Inc. Recent Developments/Updates
Table 48. WG Critical Care Basic Information, Manufacturing Base and Competitors
Table 49. WG Critical Care Major Business
Table 50. WG Critical Care Carbapenem Drugs Product and Services
Table 51. WG Critical Care Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. WG Critical Care Recent Developments/Updates
Table 53. Hanhui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Hanhui Pharmaceutical Major Business
Table 55. Hanhui Pharmaceutical Carbapenem Drugs Product and Services
Table 56. Hanhui Pharmaceutical Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Hanhui Pharmaceutical Recent Developments/Updates
Table 58. Zhuhai United Laboratories Basic Information, Manufacturing Base and Competitors
Table 59. Zhuhai United Laboratories Major Business
Table 60. Zhuhai United Laboratories Carbapenem Drugs Product and Services
Table 61. Zhuhai United Laboratories Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Zhuhai United Laboratories Recent Developments/Updates
Table 63. ACS Dobfar S.p.A Basic Information, Manufacturing Base and Competitors
Table 64. ACS Dobfar S.p.A Major Business
Table 65. ACS Dobfar S.p.A Carbapenem Drugs Product and Services
Table 66. ACS Dobfar S.p.A Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. ACS Dobfar S.p.A Recent Developments/Updates
Table 68. Iterum Therapeutics plc (ITRM) Basic Information, Manufacturing Base and Competitors
Table 69. Iterum Therapeutics plc (ITRM) Major Business
Table 70. Iterum Therapeutics plc (ITRM) Carbapenem Drugs Product and Services
Table 71. Iterum Therapeutics plc (ITRM) Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Iterum Therapeutics plc (ITRM) Recent Developments/Updates
Table 73. Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Daewoong Pharmaceutical Major Business
Table 75. Daewoong Pharmaceutical Carbapenem Drugs Product and Services
Table 76. Daewoong Pharmaceutical Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Daewoong Pharmaceutical Recent Developments/Updates
Table 78. Aurobindo Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 79. Aurobindo Pharma Ltd Major Business
Table 80. Aurobindo Pharma Ltd Carbapenem Drugs Product and Services
Table 81. Aurobindo Pharma Ltd Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Aurobindo Pharma Ltd Recent Developments/Updates
Table 83. Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 84. Sumitomo Pharma Major Business
Table 85. Sumitomo Pharma Carbapenem Drugs Product and Services
Table 86. Sumitomo Pharma Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Sumitomo Pharma Recent Developments/Updates
Table 88. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 89. Pfizer Inc. Major Business
Table 90. Pfizer Inc. Carbapenem Drugs Product and Services
Table 91. Pfizer Inc. Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Pfizer Inc. Recent Developments/Updates
Table 93. Global Carbapenem Drugs Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 94. Global Carbapenem Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 95. Global Carbapenem Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 96. Market Position of Manufacturers in Carbapenem Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 97. Head Office and Carbapenem Drugs Production Site of Key Manufacturer
Table 98. Carbapenem Drugs Market: Company Product Type Footprint
Table 99. Carbapenem Drugs Market: Company Product Application Footprint
Table 100. Carbapenem Drugs New Market Entrants and Barriers to Market Entry
Table 101. Carbapenem Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Carbapenem Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 103. Global Carbapenem Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 104. Global Carbapenem Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 105. Global Carbapenem Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 106. Global Carbapenem Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 107. Global Carbapenem Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 108. Global Carbapenem Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 109. Global Carbapenem Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 110. Global Carbapenem Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 111. Global Carbapenem Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 112. Global Carbapenem Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 113. Global Carbapenem Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 114. Global Carbapenem Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 115. Global Carbapenem Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 116. Global Carbapenem Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 117. Global Carbapenem Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 118. Global Carbapenem Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 119. Global Carbapenem Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 120. North America Carbapenem Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 121. North America Carbapenem Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 122. North America Carbapenem Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 123. North America Carbapenem Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 124. North America Carbapenem Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 125. North America Carbapenem Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 126. North America Carbapenem Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 127. North America Carbapenem Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 128. Europe Carbapenem Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 129. Europe Carbapenem Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 130. Europe Carbapenem Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 131. Europe Carbapenem Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 132. Europe Carbapenem Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 133. Europe Carbapenem Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 134. Europe Carbapenem Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 135. Europe Carbapenem Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 136. Asia-Pacific Carbapenem Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 137. Asia-Pacific Carbapenem Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 138. Asia-Pacific Carbapenem Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 139. Asia-Pacific Carbapenem Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 140. Asia-Pacific Carbapenem Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 141. Asia-Pacific Carbapenem Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 142. Asia-Pacific Carbapenem Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 143. Asia-Pacific Carbapenem Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 144. South America Carbapenem Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 145. South America Carbapenem Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 146. South America Carbapenem Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 147. South America Carbapenem Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 148. South America Carbapenem Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 149. South America Carbapenem Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 150. South America Carbapenem Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 151. South America Carbapenem Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 152. Middle East & Africa Carbapenem Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 153. Middle East & Africa Carbapenem Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 154. Middle East & Africa Carbapenem Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 155. Middle East & Africa Carbapenem Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 156. Middle East & Africa Carbapenem Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 157. Middle East & Africa Carbapenem Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 158. Middle East & Africa Carbapenem Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 159. Middle East & Africa Carbapenem Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 160. Carbapenem Drugs Raw Material
Table 161. Key Manufacturers of Carbapenem Drugs Raw Materials
Table 162. Carbapenem Drugs Typical Distributors
Table 163. Carbapenem Drugs Typical Customers
LIST OF FIGURE
s
Figure 1. Carbapenem Drugs Picture
Figure 2. Global Carbapenem Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Carbapenem Drugs Consumption Value Market Share by Type in 2023
Figure 4. Doripenem Examples
Figure 5. Ertapenem Examples
Figure 6. Imipenem Examples
Figure 7. Meropenem Examples
Figure 8. Panipenem Examples
Figure 9. Biapenem Examples
Figure 10. Global Carbapenem Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Carbapenem Drugs Consumption Value Market Share by Application in 2023
Figure 12. Hospital Examples
Figure 13. Clinic Examples
Figure 14. Others Examples
Figure 15. Global Carbapenem Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Carbapenem Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Carbapenem Drugs Sales Quantity (2019-2030) & (K Units)
Figure 18. Global Carbapenem Drugs Average Price (2019-2030) & (US$/Unit)
Figure 19. Global Carbapenem Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 20. Global Carbapenem Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 21. Producer Shipments of Carbapenem Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 22. Top 3 Carbapenem Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Top 6 Carbapenem Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Global Carbapenem Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 25. Global Carbapenem Drugs Consumption Value Market Share by Region (2019-2030)
Figure 26. North America Carbapenem Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Europe Carbapenem Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. Asia-Pacific Carbapenem Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. South America Carbapenem Drugs Consumption Value (2019-2030) & (USD Million)
Figure 30. Middle East & Africa Carbapenem Drugs Consumption Value (2019-2030) & (USD Million)
Figure 31. Global Carbapenem Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 32. Global Carbapenem Drugs Consumption Value Market Share by Type (2019-2030)
Figure 33. Global Carbapenem Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 34. Global Carbapenem Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 35. Global Carbapenem Drugs Consumption Value Market Share by Application (2019-2030)
Figure 36. Global Carbapenem Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 37. North America Carbapenem Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 38. North America Carbapenem Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 39. North America Carbapenem Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 40. North America Carbapenem Drugs Consumption Value Market Share by Country (2019-2030)
Figure 41. United States Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Canada Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Mexico Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Europe Carbapenem Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 45. Europe Carbapenem Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 46. Europe Carbapenem Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 47. Europe Carbapenem Drugs Consumption Value Market Share by Country (2019-2030)
Figure 48. Germany Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. France Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. United Kingdom Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Russia Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Italy Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Asia-Pacific Carbapenem Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 54. Asia-Pacific Carbapenem Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 55. Asia-Pacific Carbapenem Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 56. Asia-Pacific Carbapenem Drugs Consumption Value Market Share by Region (2019-2030)
Figure 57. China Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Japan Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Korea Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. India Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Southeast Asia Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Australia Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. South America Carbapenem Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 64. South America Carbapenem Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 65. South America Carbapenem Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 66. South America Carbapenem Drugs Consumption Value Market Share by Country (2019-2030)
Figure 67. Brazil Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Argentina Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Middle East & Africa Carbapenem Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 70. Middle East & Africa Carbapenem Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 71. Middle East & Africa Carbapenem Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 72. Middle East & Africa Carbapenem Drugs Consumption Value Market Share by Region (2019-2030)
Figure 73. Turkey Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Egypt Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Saudi Arabia Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. South Africa Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Carbapenem Drugs Market Drivers
Figure 78. Carbapenem Drugs Market Restraints
Figure 79. Carbapenem Drugs Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Carbapenem Drugs in 2023
Figure 82. Manufacturing Process Analysis of Carbapenem Drugs
Figure 83. Carbapenem Drugs Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Table 1. Global Carbapenem Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Carbapenem Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Shandong New Era Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Shandong New Era Pharmaceutical Major Business
Table 5. Shandong New Era Pharmaceutical Carbapenem Drugs Product and Services
Table 6. Shandong New Era Pharmaceutical Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Shandong New Era Pharmaceutical Recent Developments/Updates
Table 8. Shenzhen Haibin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 9. Shenzhen Haibin Pharmaceutical Major Business
Table 10. Shenzhen Haibin Pharmaceutical Carbapenem Drugs Product and Services
Table 11. Shenzhen Haibin Pharmaceutical Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 13. Sinopharm Guorui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. Sinopharm Guorui Pharmaceutical Major Business
Table 15. Sinopharm Guorui Pharmaceutical Carbapenem Drugs Product and Services
Table 16. Sinopharm Guorui Pharmaceutical Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Sinopharm Guorui Pharmaceutical Recent Developments/Updates
Table 18. Taiwan Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 19. Taiwan Biotech Co., Ltd. Major Business
Table 20. Taiwan Biotech Co., Ltd. Carbapenem Drugs Product and Services
Table 21. Taiwan Biotech Co., Ltd. Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Taiwan Biotech Co., Ltd. Recent Developments/Updates
Table 23. Merck Basic Information, Manufacturing Base and Competitors
Table 24. Merck Major Business
Table 25. Merck Carbapenem Drugs Product and Services
Table 26. Merck Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Merck Recent Developments/Updates
Table 28. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Sun Pharmaceutical Industries Ltd. Major Business
Table 30. Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Product and Services
Table 31. Sun Pharmaceutical Industries Ltd. Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 33. JW Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. JW Pharmaceutical Major Business
Table 35. JW Pharmaceutical Carbapenem Drugs Product and Services
Table 36. JW Pharmaceutical Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. JW Pharmaceutical Recent Developments/Updates
Table 38. Zhengde Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Zhengde Pharmaceutical Major Business
Table 40. Zhengde Pharmaceutical Carbapenem Drugs Product and Services
Table 41. Zhengde Pharmaceutical Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Zhengde Pharmaceutical Recent Developments/Updates
Table 43. Hospira Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Hospira Inc. Major Business
Table 45. Hospira Inc. Carbapenem Drugs Product and Services
Table 46. Hospira Inc. Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Hospira Inc. Recent Developments/Updates
Table 48. WG Critical Care Basic Information, Manufacturing Base and Competitors
Table 49. WG Critical Care Major Business
Table 50. WG Critical Care Carbapenem Drugs Product and Services
Table 51. WG Critical Care Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. WG Critical Care Recent Developments/Updates
Table 53. Hanhui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Hanhui Pharmaceutical Major Business
Table 55. Hanhui Pharmaceutical Carbapenem Drugs Product and Services
Table 56. Hanhui Pharmaceutical Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Hanhui Pharmaceutical Recent Developments/Updates
Table 58. Zhuhai United Laboratories Basic Information, Manufacturing Base and Competitors
Table 59. Zhuhai United Laboratories Major Business
Table 60. Zhuhai United Laboratories Carbapenem Drugs Product and Services
Table 61. Zhuhai United Laboratories Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Zhuhai United Laboratories Recent Developments/Updates
Table 63. ACS Dobfar S.p.A Basic Information, Manufacturing Base and Competitors
Table 64. ACS Dobfar S.p.A Major Business
Table 65. ACS Dobfar S.p.A Carbapenem Drugs Product and Services
Table 66. ACS Dobfar S.p.A Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. ACS Dobfar S.p.A Recent Developments/Updates
Table 68. Iterum Therapeutics plc (ITRM) Basic Information, Manufacturing Base and Competitors
Table 69. Iterum Therapeutics plc (ITRM) Major Business
Table 70. Iterum Therapeutics plc (ITRM) Carbapenem Drugs Product and Services
Table 71. Iterum Therapeutics plc (ITRM) Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Iterum Therapeutics plc (ITRM) Recent Developments/Updates
Table 73. Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Daewoong Pharmaceutical Major Business
Table 75. Daewoong Pharmaceutical Carbapenem Drugs Product and Services
Table 76. Daewoong Pharmaceutical Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Daewoong Pharmaceutical Recent Developments/Updates
Table 78. Aurobindo Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 79. Aurobindo Pharma Ltd Major Business
Table 80. Aurobindo Pharma Ltd Carbapenem Drugs Product and Services
Table 81. Aurobindo Pharma Ltd Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Aurobindo Pharma Ltd Recent Developments/Updates
Table 83. Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 84. Sumitomo Pharma Major Business
Table 85. Sumitomo Pharma Carbapenem Drugs Product and Services
Table 86. Sumitomo Pharma Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Sumitomo Pharma Recent Developments/Updates
Table 88. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 89. Pfizer Inc. Major Business
Table 90. Pfizer Inc. Carbapenem Drugs Product and Services
Table 91. Pfizer Inc. Carbapenem Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Pfizer Inc. Recent Developments/Updates
Table 93. Global Carbapenem Drugs Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 94. Global Carbapenem Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 95. Global Carbapenem Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 96. Market Position of Manufacturers in Carbapenem Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 97. Head Office and Carbapenem Drugs Production Site of Key Manufacturer
Table 98. Carbapenem Drugs Market: Company Product Type Footprint
Table 99. Carbapenem Drugs Market: Company Product Application Footprint
Table 100. Carbapenem Drugs New Market Entrants and Barriers to Market Entry
Table 101. Carbapenem Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Carbapenem Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 103. Global Carbapenem Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 104. Global Carbapenem Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 105. Global Carbapenem Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 106. Global Carbapenem Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 107. Global Carbapenem Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 108. Global Carbapenem Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 109. Global Carbapenem Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 110. Global Carbapenem Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 111. Global Carbapenem Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 112. Global Carbapenem Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 113. Global Carbapenem Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 114. Global Carbapenem Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 115. Global Carbapenem Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 116. Global Carbapenem Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 117. Global Carbapenem Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 118. Global Carbapenem Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 119. Global Carbapenem Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 120. North America Carbapenem Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 121. North America Carbapenem Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 122. North America Carbapenem Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 123. North America Carbapenem Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 124. North America Carbapenem Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 125. North America Carbapenem Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 126. North America Carbapenem Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 127. North America Carbapenem Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 128. Europe Carbapenem Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 129. Europe Carbapenem Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 130. Europe Carbapenem Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 131. Europe Carbapenem Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 132. Europe Carbapenem Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 133. Europe Carbapenem Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 134. Europe Carbapenem Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 135. Europe Carbapenem Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 136. Asia-Pacific Carbapenem Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 137. Asia-Pacific Carbapenem Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 138. Asia-Pacific Carbapenem Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 139. Asia-Pacific Carbapenem Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 140. Asia-Pacific Carbapenem Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 141. Asia-Pacific Carbapenem Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 142. Asia-Pacific Carbapenem Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 143. Asia-Pacific Carbapenem Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 144. South America Carbapenem Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 145. South America Carbapenem Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 146. South America Carbapenem Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 147. South America Carbapenem Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 148. South America Carbapenem Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 149. South America Carbapenem Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 150. South America Carbapenem Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 151. South America Carbapenem Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 152. Middle East & Africa Carbapenem Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 153. Middle East & Africa Carbapenem Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 154. Middle East & Africa Carbapenem Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 155. Middle East & Africa Carbapenem Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 156. Middle East & Africa Carbapenem Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 157. Middle East & Africa Carbapenem Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 158. Middle East & Africa Carbapenem Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 159. Middle East & Africa Carbapenem Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 160. Carbapenem Drugs Raw Material
Table 161. Key Manufacturers of Carbapenem Drugs Raw Materials
Table 162. Carbapenem Drugs Typical Distributors
Table 163. Carbapenem Drugs Typical Customers
LIST OF FIGURE
s
Figure 1. Carbapenem Drugs Picture
Figure 2. Global Carbapenem Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Carbapenem Drugs Consumption Value Market Share by Type in 2023
Figure 4. Doripenem Examples
Figure 5. Ertapenem Examples
Figure 6. Imipenem Examples
Figure 7. Meropenem Examples
Figure 8. Panipenem Examples
Figure 9. Biapenem Examples
Figure 10. Global Carbapenem Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Carbapenem Drugs Consumption Value Market Share by Application in 2023
Figure 12. Hospital Examples
Figure 13. Clinic Examples
Figure 14. Others Examples
Figure 15. Global Carbapenem Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Carbapenem Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Carbapenem Drugs Sales Quantity (2019-2030) & (K Units)
Figure 18. Global Carbapenem Drugs Average Price (2019-2030) & (US$/Unit)
Figure 19. Global Carbapenem Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 20. Global Carbapenem Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 21. Producer Shipments of Carbapenem Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 22. Top 3 Carbapenem Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Top 6 Carbapenem Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Global Carbapenem Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 25. Global Carbapenem Drugs Consumption Value Market Share by Region (2019-2030)
Figure 26. North America Carbapenem Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Europe Carbapenem Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. Asia-Pacific Carbapenem Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. South America Carbapenem Drugs Consumption Value (2019-2030) & (USD Million)
Figure 30. Middle East & Africa Carbapenem Drugs Consumption Value (2019-2030) & (USD Million)
Figure 31. Global Carbapenem Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 32. Global Carbapenem Drugs Consumption Value Market Share by Type (2019-2030)
Figure 33. Global Carbapenem Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 34. Global Carbapenem Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 35. Global Carbapenem Drugs Consumption Value Market Share by Application (2019-2030)
Figure 36. Global Carbapenem Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 37. North America Carbapenem Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 38. North America Carbapenem Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 39. North America Carbapenem Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 40. North America Carbapenem Drugs Consumption Value Market Share by Country (2019-2030)
Figure 41. United States Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Canada Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Mexico Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Europe Carbapenem Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 45. Europe Carbapenem Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 46. Europe Carbapenem Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 47. Europe Carbapenem Drugs Consumption Value Market Share by Country (2019-2030)
Figure 48. Germany Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. France Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. United Kingdom Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Russia Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Italy Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Asia-Pacific Carbapenem Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 54. Asia-Pacific Carbapenem Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 55. Asia-Pacific Carbapenem Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 56. Asia-Pacific Carbapenem Drugs Consumption Value Market Share by Region (2019-2030)
Figure 57. China Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Japan Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Korea Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. India Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Southeast Asia Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Australia Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. South America Carbapenem Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 64. South America Carbapenem Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 65. South America Carbapenem Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 66. South America Carbapenem Drugs Consumption Value Market Share by Country (2019-2030)
Figure 67. Brazil Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Argentina Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Middle East & Africa Carbapenem Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 70. Middle East & Africa Carbapenem Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 71. Middle East & Africa Carbapenem Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 72. Middle East & Africa Carbapenem Drugs Consumption Value Market Share by Region (2019-2030)
Figure 73. Turkey Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Egypt Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Saudi Arabia Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. South Africa Carbapenem Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Carbapenem Drugs Market Drivers
Figure 78. Carbapenem Drugs Market Restraints
Figure 79. Carbapenem Drugs Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Carbapenem Drugs in 2023
Figure 82. Manufacturing Process Analysis of Carbapenem Drugs
Figure 83. Carbapenem Drugs Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
